[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-338985-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-338985-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","cysteine-protease-inhibitor-1-promotes-metastasis-by-mediating-an-oxidative-phosphorylationmekerk-axis-in-esophageal-squamous-carcinoma-cancer","Cysteine protease inhibitor 1 promotes metastasis by mediating an oxidative phosphorylation/MEK/ERK axis in esophageal squamous carcinoma cancer","","Cysteine protease inhibitor 1 (CST1) is a cystatin family protein implicated in multiple malignancies, yet its connection to mitochondrial oxidative phosphorylation (OXPHOS) in esophageal squamous cell carcinoma (ESCC) is unclear. Pilot findings indicate that CST1 promotes ESCC migration and invasion through MEK/ERK pathway activation. Transcriptome sequencing links CST1 with OXPHOS, and functional assays show CST1 modulates mitochondrial complex I activity by interacting with GRIM19 to elevate OXPHOS. In vivo experiments further support CST1-driven ESCC metastasis via coordinated OXPHOS and MEK/ERK signaling, suggesting CST1/OXPHOS as a therapeutic target.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/cysteine-protease-inhibitor-1-promotes-metastasis-by-mediating-an-oxidative-phosphorylationmekerk-axis-in-esophageal-squamous-carcinoma-cancer/338985/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/cysteine-protease-inhibitor-1-promotes-metastasis-by-mediating-an-oxidative-phosphorylationmekerk-axis-in-esophageal-squamous-carcinoma-cancer/338985.png","ImageObject",300,407,{"name":42,"@type":43},"Anda","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-04","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is CST1 and what role does it play in ESCC?","Question",{"text":63,"@type":64},"CST1 is a cystatin superfamily protein. The study shows CST1 can promote ESCC migration and invasion and contributes to metastasis through the OXPHOS/MEK/ERK signaling axis.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does CST1 influence oxidative phosphorylation in ESCC cells?",{"text":68,"@type":64},"CST1 is associated with OXPHOS and affects mitochondrial complex I activity. It interacts with GRIM19 to elevate OXPHOS levels in ESCC cells.",{"name":70,"@type":61,"acceptedAnswer":71},"What is the relationship between OXPHOS and the MEK/ERK pathway in this study?",{"text":72,"@type":64},"The work indicates a reciprocal regulatory relationship between OXPHOS and MEK/ERK signaling in ESCC cells. CST1 activates MEK/ERK, while OXPHOS contributes to phosphorylation of key proteins in the MEK/ERK pathway.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},338985,1790191006,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":109,"preview_page_count":33,"preview_urls":145},962075006959,"https://ap-avatar.wpscdn.com/avatar/e0002397efbe92a78e?_k=1776741047341049297","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nCysteine protease inhibitor 1 promotes metastasis by mediating an oxidative phosphorylation/MEK/ ERK axis in esophageal squamous carcinoma cancer  \nLiangming Zhang1,2, Xiongfeng Chen1,3, Jianwei Wang1,2, Meihong Chen1,2, Juan Chen1,4, Wanzhen Zhuang1,5, Yu Xia5,6, Zhixin Huang5,6, Yue Zheng1,5 & Yi Huang1,5,7,8*  \nCysteine protease inhibitor 1 (CST1) is a cystatin superfamily protein that inhibits cysteine protease activity and is reported to be involved in the development of many malignancies. Mitochondrial oxidative phosphorylation (OXPHOS) also plays an important role in cancer cell growth regulation. However, the relationship and roles of CST1 andOXPHOS in esophageal squamous cell carcinoma (ESCC) remains unclear. In our pilot study, CST1 was shown the potential of promoting ESCC migration and invasion by the activation of MEK/ERK pathway. Transcriptome sequencing analysis revealed that CST1 is closely associated with OXPHOS. Based on a real-time ATP rate assay, mitochondrial complex I enzyme activity assay, immunofluorescence, co-immunoprecipitation, and addition of theOXPHOS inhibitor Rotenone and MEK/ERK inhibitor PD98059, we determined that CST1 affects mitochondrial complex I enzyme activity by interacting with the GRIM19 protein to elevate OXPHOS levels, and a reciprocal regulatory relationship exists between OXPHOS and the MEK/ERK pathway in ESCC cells. Finally, an in vivo study demonstrated the potential of CST1 in ESCC metastasis through regulation of theOXPHOS and MEK/ERK pathways. This study is the first to reveal the oncogenic role of CST1 in ESCC development by enhancing mitochondrial respiratory chain complex I activity to activate the OXPHOS/MEK/ERK axis, and then promote ESCC metastasis, suggesting that CST1/OXPHOS is a promising target for ESCC treatment.  \nKeywords CST1, Esophageal squamous cell carcinoma, Oxidative phosphorylation, MEK/ERK pathway  \nEsophageal cancer is the eighth most frequent cancer and the sixth leading cause of cancer-related deaths worldwide, accounting for more than 500,000 deaths annually1, which can be classified as esophageal squamous cell carcinoma (ESCC) and esophageal adenocarcinoma (EAC)2. Over the last few years, ESCC has been reported to have a noticeably higher incidence rate than that ofEAC, as well as a dismal five-year survival rate of 5–20%3,4. Unfortunately, China presents the highest incidence of ESCC, accounting for more than 50% of new cases worldwide5. Therefore, exploring the pathogenesis ofESCC and identifying early screening indicators are crucial. Oxidative phosphorylation (OXPHOS) and glycolysis are the two critical energy metabolic pathways in mammalian cells6–10. OXPHOS occurs mainly through the cellular mitochondrial respiratory chain complex pathway to synthesize large amounts of ATP to meet the daily needs of the cells11–13. There is growing evidence  \n1Shengli Clinical Medical College, Fujian Medical University, No.134 East Street, Fuzhou 350001, Fujian Province, China. 2Department of Clinical Laboratory, Fujian Provincial Hospital South Branch, Fuzhou 350008, Fujian, China. 3Department of Scientific Research, Fujian Provincial Hospital, Fuzhou 350001, Fujian, China. 4Clinical Laboratory Department of Fuding Hospital, Fujian University of Traditional Chinese Medicine, Fuding 355200, Fujian, China. 5Department of Clinical Laboratory, Fujian Provincial Hospital, Fuzhou 350001, Fujian, China. 6Integrated Chinese and Western Medicine College, Fujian University of Traditional Chinese Medicine, Fuzhou 350000, Fujian, China. 7Central Laboratory, Center for Experimental Research in Clinical Medicine, Fujian Provincial Hospital, Fuzhou 350001, Fujian, China. 8Fujian Provincial Key Laboratory of Critical Care Medicine, Fujian Provincial Key Laboratory of Cardiovascular Disease, Fuzhou 350001, Fujian, China. *email: [hyi8070@126.com](hyi8070@126.com)  \n[www. nature.com/scientificrepor","cbCaiamTGlUxSLOr","https://ap.wps.com/l/cbCaiamTGlUxSLOr","pdf",6292598,16,"English","# Materials and methods\n## Cell culture\n## Vector transfection","[{\"question\":\"What is CST1 and what role does it play in ESCC?\",\"answer\":\"CST1 is a cystatin superfamily protein. The study shows CST1 can promote ESCC migration and invasion and contributes to metastasis through the OXPHOS/MEK/ERK signaling axis.\"},{\"question\":\"How does CST1 influence oxidative phosphorylation in ESCC cells?\",\"answer\":\"CST1 is associated with OXPHOS and affects mitochondrial complex I activity. It interacts with GRIM19 to elevate OXPHOS levels in ESCC cells.\"},{\"question\":\"What is the relationship between OXPHOS and the MEK/ERK pathway in this study?\",\"answer\":\"The work indicates a reciprocal regulatory relationship between OXPHOS and MEK/ERK signaling in ESCC cells. CST1 activates MEK/ERK, while OXPHOS contributes to phosphorylation of key proteins in the MEK/ERK pathway.\"}]","Cysteine protease inhibitor 1 promotes metastasis by mediating an oxidative phosphorylation/MEK/ERK axis in esophageal squamous carcinoma cancer | PDF",1790027006,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/036d2cdc47d81c9afaf7c7985d3836ff.webp",983,1291,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c73ce4d035fec8563bfa5bcf66272d40.webp",982,1290,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e0d385e973196f0c55dcca93db773b6c.webp",981,1289,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ca3a30841980532c3b3f83f309d312a0.webp",980,1287]